164 results
Page 4 of 9
8-K
EX-99.1
ku78c uv2hyg4ob52s2
2 Aug 12
Discovery Labs Reports Second Quarter 2012 Financial Results
12:00am
424B5
8o4olrmma90
19 Mar 12
Prospectus supplement for primary offering
12:00am
424B5
9y5 2mopp4necif
15 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
7bnpq3h5z8imcm0f3
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
424B5
5eng09ty94og3qenn
15 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
hyyjo 0zdi4s
29 Jul 11
Other Events
12:00am
8-K
EX-99.1
f2b46ag0lg
1 Jun 11
Other Events
12:00am
8-K
EX-99.1
imh8zfdg7gxq3
11 May 11
Results of Operations and Financial Condition
12:00am
424B5
s7e3kcx ycxhi1vn
17 Feb 11
Prospectus supplement for primary offering
12:00am
424B5
ib1eyy kfa05
15 Feb 11
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
null7mtglv
9 Feb 11
Other Events
12:00am